CRISPR's Limitations in Mitochondrial DNA Editing and Emerging Alternatives
By
ck2
Hot, fresh, and worth queueing round the block for.
Summary
The article discusses the limitations of CRISPR gene editing technology in accessing mitochondrial DNA (mtDNA) and the resulting challenges in treating mitochondrial diseases. While CRISPR has revolutionized many areas of biology and medicine, it cannot easily reach the DNA inside mitochondria, leaving precise edits to mtDNA frustratingly difficult. However, researchers are exploring alternative approaches to overcome this barrier and develop treatments for mitochondrial disorders.
Key quotes
· 4 pulledCRISPR gene editing has made its way into every corner of modern biology, but not into every corner of the cell.
There's one place CRISPR can't easily reach: mitochondria.
The rings of DNA inside mitochondria are inaccessible to these techniques, which means that precise edits to mitochondrial DNA (mtDNA) remain frustrating.
CRISPR-based tools can't easily access the DNA in these organelles, but researchers are finding other ways in.
You might also wanna read
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·2h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·20h ago
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago
Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·3d agoStartup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
science.org·3d ago
Penn researchers develop bioengineered chewing gum with potential to prevent oral and head cancers
Researchers at Penn, led by Dr. Henry Daniell, have developed a bioengineered chewing gum made from a bean plant that contains antiviral, an
whyy.org·3d ago